Phase I Study of RiMO-401 With Radiation in Advanced Tumors

Clinical trial NCT06182579 · TERMINATED

Trial details

NCT number: NCT06182579
Sponsor: Coordination Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Intratumoral Injection

Start date: 2024-02-22
Primary completion: 2025-06-16
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.